$AVAH

J.H. Whitney Equity Partners VII, LLC sold $19.4M of AVAH (indirect holdings)

J.H. Whitney Equity Partners VII, LLC sold 2,419,035 indirectly-held shares of Aveanna Healthcare Holdings, Inc. (AVAH) at $8.01 ($19.38M total) on 2026-06-30.

Original reporting
SEC EDGAR · J.H. Whitney Equity Partners VII, LLC
Published Jul 2, 2026, 4:09 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 2, 2026, 4:19 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$AVAH
Bearish
medium confidence
Mentioned
$AVAH
Relevance
7/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AVAHBearishLow
01

Why it matters

Traders may reassess short-term sentiment around AVAH due to the disclosed $19.4M sale, but there is no accompanying new business or financial datapoint in the text.

02

Market read

Primary insider-sale disclosure for AVAH; potential modest sentiment impact, but no fundamental catalyst provided.

03

What to watch

Indirect holdings and the absence of a stated 10b5-1 plan can complicate interpretation; without follow-on buys/sells or guidance changes, fundamental impact is uncertain.

Relevance 7/10Novelty 6/10Timing: SEC Form 4 filed 2026-07-02 for a 2026-06-30 sale

Background

The filing is an SEC Form 4 insider transaction: J.H. Whitney Equity Partners VII, LLC (10% owner) sold shares indirectly in an open-market transaction.

Company-level read

Ticker impact

$AVAHBearishMedium confidence
Context

Aveanna Healthcare Holdings disclosed a 10% owner indirect open-market sale of 2,419,035 shares at $8.01 on 2026-06-30.

Expected impact

Likely small, short-lived negative bias; no clear directional catalyst beyond typical insider-sale interpretation.

Evidence & confidence

This is a primary SEC Form 4 disclosure with transaction size (~$19.4M) and role (10% owner), but it provides no new operating, guidance, or regulatory information.

Market effects

Limited read-through to the healthcare services/behavioral health space; this is company-specific insider activity.

None indicated; US-listed issuer filing only.

None indicated.

Counterpoint

A 10% owner may sell for diversification/liquidity or tax reasons (especially with no 10b5-1 plan stated), so the signal may be less informative than it appears.

Key entities

  • Aveanna Healthcare Holdings, Inc.

    US-listed company (AVAH) whose shares were sold via an indirect open-market sale by a 10% owner.

  • J.H. Whitney Equity Partners VII, LLC

    10% owner reporting an indirect open-market sale of 2,419,035 shares.

Related articles

$AVAHMed

Bain, KKR, KV Asia shortlisted for Malaysia’s Avisena Healthcare stake sale as valuation hits US$368 million: sources

Bain Capital, KKR and KV Asia have been shortlisted to buy a 20–25% minority stake in Malaysia’s Avisena Healthcare, valuing the company at about RM1.5 billion (US$368m), according to two sources. Binding bids are due by end-July. The stake is estimated at RM300–400m. KKR and Bain declined comment; Avisena and KV Asia did not respond.